newsfilter.io

PRPOPrecipio, Inc.

  1. GlobeNewswire

    Precipio Announces Q2-2026 Financial Results

    NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces financial results for the second quarter that ended June 30, 2026. Below are some of ...

  2. GlobeNewswire

    Precipio Announces Q2-2026 Shareholder Update Call

    NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET. The call ...

  3. GlobeNewswire

    Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting

    NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) is requesting that shareholders instruct their brokers to vote their shares ...

  4. GlobeNewswire

    Precipio to Present at the Planet MicroCap Las Vegas

    NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, ...

  5. GlobeNewswire

    Precipio Announces Q1 2026 Financial Results

    NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces financial results for the first quarter ended March 31, 2026. Below are some of the key ...

  6. GlobeNewswire

    Management team's 2025 market-based Options have vested

    NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces that 2025 employee stock options granted to certain members of Precipio's management team ...

  7. GlobeNewswire

    Precipio Announces Q1-2026 Shareholder Update Call

    NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET. The call will ...

  8. GlobeNewswire

    Precipio Announces Q4 and year-end 2025 Shareholder Update Call

    NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q4 and year end 2025 corporate update call on April 2nd, 2026 at 5:00 PM ET. ...

  9. GlobeNewswire

    Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay

    NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has announced the publication1 in the Journal of Clinical Pathology of a study conducted in ...

  10. GlobeNewswire

    Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year

    NEW HAVEN, Conn., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaudited) financials for Q4-2025 and for its fiscal year 2025. Below ...

  11. GlobeNewswire

    Precipio Takes Major Steps Toward a Clean Balance Sheet

    NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has made major strides in cleaning up its balance sheet with two major accomplishments: 1. Major ...

  12. GlobeNewswire

    Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting

    NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) will be presenting at ASH the findings of a joint study conducted with scientific collaborators from ...

  13. GlobeNewswire

    Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

    NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its secure cloud file ...

  14. GlobeNewswire

    Precipio Announces its Q3-2025 Financial Results

    NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), filed its 10-Q report today. The following are the highlights of the Company's financial ...

  15. GlobeNewswire

    Precipio Announces Q3-2025 Shareholder Update Call

    NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:00 PM ET. The call ...

  16. SEC

    4 Form - Statement of changes in beneficial ownership of securities - Precipio, Inc. (0001043961) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  17. SEC

    4 Form - Statement of changes in beneficial ownership of securities - Precipio, Inc. (0001043961) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  18. SEC

    4 Form - Statement of changes in beneficial ownership of securities - Precipio, Inc. (0001043961) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  19. SEC

    4 Form - Statement of changes in beneficial ownership of securities - Precipio, Inc. (0001043961) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  20. SEC

    SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - Precipio, Inc. (0001043961) (Subject)

    Statement of Beneficial Ownership by Certain Investors ...

  21. SEC

    4 Form - Statement of changes in beneficial ownership of securities - Precipio, Inc. (0001043961) (Issuer)

    Statement of changes in beneficial ownership of securities ...

  22. SEC

    144 Form - Report of proposed sale of securities - Precipio, Inc. (0001043961) (Subject)

    Report of proposed sale of securities ...

  23. SEC

    8-K Form - Current report, items 1.02 and 9.01 - Precipio, Inc. (0001043961) (Filer)

    Current report, items 1.02 and 9.01 ...

  24. GlobeNewswire

    Precipio Terminates Its ATM

    NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners ...

  25. Earnings Call Transcripts

    Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript

    Precipio, Inc. (PRPO) Q2 2025 Earnings Call Transcript ...